Bioluminescence imaging of vascular endothelial growth factor promoter activity in murine mammary tumorigenesis

Molecular Imaging

Volumn 6, Issue 5, 2007, Pages 331-339

  Takahashi, Takamune ^a   Foley, Shannon L ^b   Takahashi, Keiko ^b   Crooke, Cornelia E ^b   Beckham, Joshua T ^b   Tomemori, Takuya ^b   Shappell, Scott B ^b   Jansen, E Duco ^b  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

MURINE MAMMARY TUMORIGENESIS; VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF); WOUND HEALING;

BIOLUMINESCENCE; CELL GROWTH; ENZYMES; GROWTH KINETICS; MAMMALS; TUMORS;

ENDOTHELIAL CELLS;

GREEN FLUORESCENT PROTEIN; HYBRID PROTEIN; LUCIFERASE; VASCULOTROPIN A;

ANIMAL; ARTICLE; EXPERIMENTAL NEOPLASM; FEMALE; GENETICS; HUMAN; IMMUNOPRECIPITATION; IN SITU HYBRIDIZATION; LUMINESCENCE; MALE; METABOLISM; METHODOLOGY; MOUSE; PATHOLOGY; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSGENIC MOUSE; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; FEMALE; GREEN FLUORESCENT PROTEINS; HUMANS; IMMUNOPRECIPITATION; IN SITU HYBRIDIZATION; LUCIFERASES; LUMINESCENT MEASUREMENTS; MALE; MAMMARY NEOPLASMS, ANIMAL; MICE; MICE, TRANSGENIC; PROMOTER REGIONS (GENETICS); RECOMBINANT FUSION PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 35548983086     PISSN: 15353508     EISSN: None     Source Type: Journal    
DOI: 10.2310/7290.2007.00029     Document Type: Article

References (35)

1. Ferrara N. Vascular endothelial growth factor basic science and clinical progress. Endocr Rev 2004;25:581-611.
2. Linderholm BK, Lindh B, Beckman L, et al. Prognostic correlation of basic fibroblast growth factor and vascular endothelial growth factor in 1307 primary breast cancers. Clin Breast Cancer 2003;4: 340-7.
3. Klein M, Vignaud JM, Hennequin V, et al. Increased expression of the vascular endothelial growth factor is a pejorative prognosis marker in papillary thyroid carcinoma. J Clin Endocrinol Metab 2001;86:656-8.
4. Kim KJ, Li B, Winer J, et al. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature 1993;362:841-4.
5. Loureiro RM, D'Amore PA. Transcriptional regulation of vascular endothelial growth factor in cancer. Cytokine Growth Factor Rev 2005;16:77-89.
6. Forsythe JA, Jiang BH, Iyer NV, et al. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol 1996;16:4604-13.
7. Pugh CW, Ratcliffe PJ. Regulation of angiogenesis by hypoxia: role of the HIF system. Nat Med 2003;9:677-84.
8. Blouw B, Song H, Tihan T, et al. The hypoxic response of tumors is dependent on their microenvironment. Cancer Cell 2003;4:133-46.
9. Liang Y, Li XY, Rebar EJ, et al. Activation of vascular endothelial growth factor A transcription in tumorigenic glioblastoma cell lines by an enhancer with cell type-specific DNase I accessibility. J Biol Chem 2002;277:20087-94.
10. Rak J, Mitsuhashi Y, Sheehan C, et al. Oncogenes and tumor angiogenesis: differential modes of vascular endothelial growth factor up-regulation in ras-transformed epithelial cells and fibroblasts. Cancer Res 2000;60:490-8.
11. Welsh DK, Kay SA. Bioluminescence imaging in living organisms. Curr Opin Biotechnol 2005;16:73-8.
12. Fukumura D, Xavier R, Sugiura T, et al. Tumor induction of VEGF promoter activity in stromal cells. Cell 1998;94:715-25.
13. Tischer E, Mitchell R, Hartman T, et al. The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. J Biol Chem 1991;266: 11947-54.
14. Guy CT, Cardiff RD, Muller WJ. Induction of mammary tumors by expression of Polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease. Mol Cell Biol 1992;12:954-61.
15. Choy G, O'Connor S, Diehn FE, et al. Comparison of noninvasive fluorescent and bioluminescent small animal optical imaging. Biotechniques 2003;35:1022-30.
16. Hogan B, Beddington R, Costantini F, Lacy E. Manipulating the mouse embryo. A laboratory manual. Plainview (NY): Cold Spring Harbor Laboratory Press; 1994.
17. Day RN, Kawecki M, Berry D. Dual-function reporter protein for analysis of gene expression in living cells. Biotechniques 1998;25: 848-4, 856.
18. Boudreau N, Myers C. Breast cancer-induced angiogenesis: multiple mechanisms and the role of the microenvironment. Breast Cancer Res 2003;5:140-6.
19. Sledge GW Jr, Vascular endothelial growth factor in breast cancer: biologic and therapeutic aspects. Semin Oncol 2002;29:104-10.
20. Fukumura D, Xu L, Chen Y, et al. Hypoxia and acidosis independently up-regulate vascular endothelial growth factor transcription in brain tumors in vivo. Cancer Res 2001;61:6020-4.
21. Schafer G, Cramer T, Suske G, et al. Oxidative stress regulates vascular endothelial growth factor-A gene transcription through Sp1- and Sp3-dependent activation of two proximal GC-rich promoter elements. J Biol Chem 2003;278:8190-8.
22. Ng YS, Rohan R, Sunday ME, et al. Differential expression of VEGF isoforms in mouse during development and in the adult. Dev Dyn 2001;220:112-21.
23. Hanahan D, Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 1996;86:353-64.
24. Lin EY, Jones JG, Li P, et al. Progression to malignancy in the polyoma middle T oncoprotein mouse breast cancer model provides a reliable model for human diseases. Am J Pathol 2003; 163:2113-26.
25. Edinger M, Cao YA, Hornig YS, et al. Advancing animal models of neoplasia through in vivo bioluminescence imaging. Eur J Cancer 2002;38:2128-36.
26. Lee AH, Dublin EA. Bobrow LG, Poulsom R. Invasive lobular and invasive ductal carcinoma of the breast show distinct patterns ofvascular endothelial growth factor expression and angiogenesis. J Pathol 1998;185:394-401.
27. Brown LF, Guidi AJ, Schnitt SJ, et al. Vascular stroma formation in carcinoma in situ, invasive carcinoma, and metastatic carcinoma of the breast. Clin Cancer Res 1999;5:1041-56.
28. Troy T, Jekic-McMullen D, Sambucetti L, Rice B. Quantitative comparison of the sensitivity of detection of fluorescent and bioluminescent reporters in animal models. Mol Imaging 2004;3: 9-23.
29. Gerber HP, Wu X, Yu L, et al. Mice expressing a humanized form of VEGF-A may provide insights into the safety and efficacy of anti-VEGF antibodies. Proc Natl Acad Sci U S A 2007;104:3478-83.
30. Shima DT, Kuroki M, Deutsch U, et al. The mouse gene for vascular endothelial growth factor. Genomic structure, definition of the transcriptional unit, and characterization of transcriptional and post-transcriptional regulatory sequences. J Biol Chem 1996; 271:3877-83.
31. Kishimoto J, Ehama R, Ge Y, et al. In vivo detection of human vascular endothelial growth factor promoter activity in transgenic mouse skin. Am J Pathol 2000;157:103-10.
32. Carmeliet P, Ferreira V, Breier G, et al. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 1996;380:435-9.
33. Ferrara N, Carver-Moore K, Chen H, et al. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 1996;380:439-42.
34. Monsky WL, Mouta CC, Tsuzuki Y, et al. Role of host microenvironment in angiogenesis and microvascular functions in human breast cancer xenografts: mammary fat pad versus cranial tumors. Clin Cancer Res 2002;8:1008-13.
35. Tsuzuki Y, Mouta CC, Bockhorn M, et al. Pancreas microenvironment promotes VEGF expression and tumor growth: novel window models for pancreatic tumor angiogenesis and microcirculation. Lab Invest 2001;81:1439-51.